Davidson Capital Management
UTHR icon

Davidson Capital Management’s United Therapeutics UTHR Stock Holding History

Davidson Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.1M Buy
11,252
+297
+3% +$154K 1.01% 27
2026
Q2 		$5.94M Buy
10,955
+182
+2% +$102K 0.95% 26
2026
Q1 		$6.39M Buy
10,773
+10,748
+42,992% +$5.35M 1.16% 12
2025
Q4 		$12.2K Buy
+25
New +$11.6K ﹤0.01% 78

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Davidson Capital Management's UTHR Position: Q3 2026 in Review

Davidson Capital Management increased its United Therapeutics (UTHR) stake by 2.7% in Q3 2026, buying an estimated $154K and bringing the position to 11,252 shares worth $6.1M. The position accounts for 1.01% of the portfolio, ranked #27.

Davidson Capital Management first reported a position in UTHR in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.39M in Q1 2026. 369 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Davidson Capital Management held 11,252 shares of United Therapeutics worth $6.1M as of Q3 2026.
  • Davidson Capital Management bought 297 United Therapeutics shares in Q3 2026, an estimated $154K.
  • United Therapeutics made up 1.01% of Davidson Capital Management's portfolio in Q3 2026, its #27 holding.
  • Davidson Capital Management first reported a position in United Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Davidson Capital Management's United Therapeutics position peaked at $6.39M in Q1 2026.
  • 369 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.